Correction to: Nature Cancer https://doi.org/10.1038/s43018-021-00304-7, published online 21 December 2021.
In the version of this article initially published, there was a typo in the Fig. 1 caption. In the text now reading, in part, “Secondary mutations in KRAS, such as those resulting in the A59G or Q61L substitutions,” “A59G” replaces “A549G” from the original version. The change has been made to the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosell, R., Aguilar, A., Pedraz, C. et al. Author Correction: KRAS inhibitors, approved. Nat Cancer 3, 518 (2022). https://doi.org/10.1038/s43018-022-00372-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-022-00372-3
